Managing irAEs with checkpoint inhibitors

This is the lay version of the EULAR ‘points to consider’ for the diagnosis and management of rheumatic immune-related side effects in people taking checkpoint inhibitors for cancer. The original publication can be downloaded from the EULAR website: www.eular.org. Kostine M, et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related […]

Read More…

Managing PsA with pharmacological therapies

This is the lay version of the 2019 update of the EULAR recommendations for the management of psoriatic arthritis using pharmacological medicines. The original publication can be downloaded from the EULAR website: www.eular.org. Gossec L, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis 2020;79:700–712. doi:10.1136/annrheumdis-2020-217159 […]

Read More…

Managing RA with DMARDs

This is the lay version of the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis using synthetic and biologic disease-modifying antirheumatic drugs. The original publication can be downloaded from the EULAR website: www.eular.org. Smolen JS, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic […]

Read More…

Managing lupus nephritis

This is the lay version of the 2019 update of the EULAR recommendations for the management of people with lupus nephritis. The original publication can be downloaded from the EULAR website: www.eular.org. Fanouriakis A, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations […]

Read More…

Overlap in symptoms of rheumatic flare and COVID-19 may delay diagnosis

People with rheumatic diseases are more likely to suffer from severe symptoms of COVID-19. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours […]

Read More…

No additional risk from COVID-19 for people with rheumatic diseases taking biologics and JAK inhibitors

There is no need for withdrawal of DMARDs during the COVID-19 pandemic. Introduction COVID-19 is caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]

Read More…

Sjögren’s syndrome

This is the lay version of the EULAR recommendations for the use of topical and systemic treatments in people with Sjögren’s syndrome. The original publication can be downloaded from the EULAR website: www.eular.org. Ramos-Casals M, et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann Rheum Dis 2020;79:3–18. doi:10.1136/annrheumdis-2019-216114 Introduction […]

Read More…

Vaccination for people with AIIRD

This is the lay version of the EULAR recommendations for vaccination in adults with autoimmune inflammatory rheumatic diseases (often shortened to AIIRD). The original publication can be downloaded from the EULAR website: www.eular.org. Furer V, et al. 2019 Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020 […]

Read More…

The role of the nurse in inflammatory arthritis

This is the lay version of the updated EULAR recommendations for the role of the nurse in managing chronic inflammatory arthritis. The original publication can be downloaded from the EULAR website: www.eular.org. Bech B, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. […]

Read More…

Managing antiphospholipid syndrome

This is the lay version of the EULAR recommendations for the management of antiphospholipid syndrome in adults. The original publication can be downloaded from the EULAR website: www.eular.org. Tektonidou MG, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults Ann Rheum Dis 2019;78(10):1296–1304. doi:10.1136/annrheumdis-2019-215213 Introduction EULAR recommendations give advice to doctors, nurses […]

Read More…